The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pyrotinib in the first-line treatment of HER2-positive advanced breast cancer: Results from the PRETTY study.
 
Yiqun Li
No Relationships to Disclose
 
Zhongsheng Tong
No Relationships to Disclose
 
Xinhong Wu
No Relationships to Disclose
 
Quchang Ouyang
No Relationships to Disclose
 
Li Cai
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Zhiyong Yu
No Relationships to Disclose
 
Zhengxiang Han
No Relationships to Disclose
 
Xiaojia Wang
No Relationships to Disclose
 
Man Li
No Relationships to Disclose
 
Haibo Wang
No Relationships to Disclose
 
Li Li
No Relationships to Disclose
 
Jin Yang
No Relationships to Disclose
 
Zhaofeng Niu
No Relationships to Disclose
 
Qitang Wang
No Relationships to Disclose
 
Binghe Xu
Consulting or Advisory Role - AstraZeneca; Novartis